Skip to sources
Time Machine

Medical Dosimetrists

Scrub through 85years of this role's history, from when it first emerged, through every wave of technology that reshaped it, to the cited projections for where it's heading next.

2026drag to travel through time
19752000now
2026
Known today as Medical Dosimetrists (BLS SOC 29-2036)
Latest actual · 2024
5K
BLS Occupational Outlook Handbook May 2024 estimate. O*NET and BLS OOH both cite approximately 4,800 jobs as of 2024. The OOH projects 3% employment growth from 2024-2034, driven by aging population cancer demand. Note: the deep-tier curated file (29-2036.00.ts) cited 8,200 from an earlier O*NET data pull; the 4,800 figure from the BLS OOH and the current O*NET summary page is the current official estimate. The 4,800 figure is used here as the projection baseline.
Latest actual · 2024
$138,110
BLS OEWS May 2024 via O*NET. Medical dosimetrists are among the highest-compensated technologist-level (non-physician, non-nurse) occupations in the entire BLS dataset. The 2024 wage represents substantial real-terms growth from the early 2010s, driven by rising demand, a tight supply of CMD-credentialed practitioners, and the premium that AI-adjacent expertise (adaptive planning, KBP governance) commands at leading cancer centers.
Each dot is a cited figure over time; the dotted line only links them (values between aren't measured). Hollow dots are estimates.
Tools of the era

The tools that defined the work

Select an era to see how it reshaped the work.

  • Hand calculation and isodose atlases (pencil-and-paper treatment planning)

    The entire art of treatment planning in the 1950s-1960s consisted of hand-drawn isodose curves, physical phantoms, and mechanical calculators. A dosimetry technician would position a transparent isodose template over a cross-sectional tracing of the patient anatomy, trace beam contributions in pencil at each point, and sum them numerically. For a simple two-field cobalt plan this might take hours; for a complex multi-field arrangement it could take days. The cobalt-60 units introduced in 1951 created the clinical demand for this work: their superior penetration required precise dose calculation at depth, something that could not be eyeballed from older orthovoltage tables. The first linac in the US was installed at Stanford in 1956, accelerating the demand. This era defined the core dosimetrist competency as geometric precision, physics knowledge, and patient-specific calculation under clinical time pressure.

    Effect on the work

    Manual calculation set a hard ceiling on how many patients a single dosimetrist could plan: treatment complexity limited throughput more than patient volume. This constraint directly drove the growth of the dosimetry workforce as cancer centers scaled up megavoltage therapy through the 1960s.

    Work toolChanging equipment
  • Early commercial treatment planning computers (RAD 8, PC-12, 2D and early 3D systems)

    The RAD 8 minicomputer treatment planning system, produced by Digital Equipment Corporation in 1968, was the first commercial treatment planning system in the United States. It used a 16K PDP 8E minicomputer and enabled automated dose distribution computation that previously required days of hand calculation. By the 1970s, computerized treatment planning was spreading from academic to community cancer centers, and the early 3D planning programs developed by researchers at multiple institutions were beginning to exploit CT imaging for anatomically accurate dose calculation. For the dosimetrist, the computer did not eliminate the role but profoundly changed its content: from manual calculator to system operator, from pencil tracing to keyboard entry, and from single-beam sketcher to multi-field planner who could iterate rapidly through beam arrangements. The AAMD organized in 1975 precisely because this computerizing, expanding workforce needed a professional home.

    Effect on the work

    Computerization increased throughput substantially, allowing one dosimetrist to plan more patients per day than was possible manually. But IMRT's emergence in the 1990s would reverse this productivity gain by making each plan far more complex, creating persistent workforce demand.

    Work toolChanging equipment
  • CMD credential + 3D conformal planning (CT-based, DVH, multi-field optimization)

    The Medical Dosimetrist Certification Board incorporated in 1988 and issued the first CMD credentials, transforming a de facto specialty into a credentialed profession. The timing was not coincidental: 3D conformal radiation therapy was moving from research to clinical practice, and the complexity of CT-based planning demanded practitioners whose competence could be documented. Dose-volume histograms, proposed by Lynn Verhey and Michael Goitein in 1979, became a standard clinical tool for evaluating 3D plans against dose constraints for each organ at risk. Where 2D planning had required geometric skill, 3D planning required the dosimetrist to understand dose-volume tradeoffs, fractionation biology, and organ-specific dose tolerance. The CMD credential codified this knowledge requirement. By the late 1990s, most academic cancer centers expected CMD certification for new hires.

    Work toolChanging equipment
  • IMRT and forward-to-inverse planning (Varian CadPlan/Helios, TomoTherapy, first IMRT patients 1994-1995)

    Intensity-modulated radiation therapy changed the dosimetrist's core task more fundamentally than any prior technology. The first IMRT patient was treated at Baylor College of Medicine in 1994 using the Nomos MIMiC system; dynamic multileaf collimator IMRT followed at Memorial Sloan Kettering in 1995. IMRT uses inverse planning: rather than selecting beam angles and calculating the resulting dose, the dosimetrist specifies dose constraints for target and organs at risk, and a computer optimizer finds beam intensity patterns that satisfy those constraints. This shifted the dosimetrist from forward planning (calculating what a given beam arrangement delivers) to constraint specification and plan quality evaluation (deciding what a good plan looks like and whether the optimizer found it). The planning time per patient increased dramatically: where a 3D conformal plan might take one to two hours, an IMRT head and neck plan could require a full day of iterative optimization. This created persistent workforce demand even as computing power expanded.

    Effect on the work

    IMRT adoption is the primary driver of dosimetry workforce growth from the late 1990s through 2015. IMRT required more dosimetrist time per patient than 3D-CRT; as IMRT became the standard of care for head and neck, prostate, and most other anatomic sites, cancer centers needed more dosimetrists to maintain throughput.

    Work toolChanging equipment
  • JRCERT accreditation + VMAT + SBRT/SRS (formal education standards, arc therapy, ablative precision)

    Two parallel developments in the mid-2000s reshaped what it meant to become a dosimetrist. First, JRCERT adopted accreditation standards for medical dosimetry educational programs in 2004 (implemented January 1, 2004), creating a formal academic pathway that replaced the previous apprenticeship-dominant model; by 2026 there were 17 JRCERT-accredited programs nationally. Second, volumetric modulated arc therapy (VMAT), developed at the University of Wisconsin and commercially deployed by Varian around 2007, dramatically reduced IMRT treatment times by delivering intensity-modulated dose during continuous gantry rotation. SBRT and SRS were also entering wide clinical use for lung, spine, liver, and brain tumors, requiring dosimetrists to master steep dose gradients, sub-millimeter precision, and ablative dose levels that were unforgiving of planning error. The dosimetry toolbox in this era required expertise in Eclipse or RayStation at the clinical level and deep knowledge of IMRT/VMAT optimization for multiple treatment sites.

    Work toolChanging equipment
  • Knowledge-based planning (RapidPlan KBP) and automated planning (Radformation AutoPlan)

    Varian's RapidPlan, commercially deployed around 2015, was the first widely adopted machine-learning system for routine treatment planning. RapidPlan trains on an institution's historical plan library to predict achievable dose-volume histogram ranges for each organ at risk given a new patient's anatomy, then automatically converts those predictions into optimization objectives. Clinical validation showed 40-70% reduction in routine planning time at deployment sites (Red Journal 2015; IJROBP 2022). Radformation AutoPlan (2019) extended this further by executing scripted beam arrangements and constraint template application, enabling push-button plan generation for routine sites (prostate, breast, head and neck, lung). The dosimetrist's role in these workflows shifted from plan generation to plan quality evaluation: does the automatically generated plan meet clinical standards, and if not, why? This is a cognitively demanding task but a fundamentally different one from the labor-intensive manual optimization it replaced.

    Effect on the work

    Institutions deploying RapidPlan and AutoPlan report routine prostate VMAT planning time reducing from 2-4 hours to 15-30 minutes. This productivity gain has not led to dosimetrist layoffs at most sites, but it has changed the composition of daily work and raised the bar on what "value-added" dosimetrist contributions look like.

    Work toolChanging equipment
  • AI auto-planning + adaptive radiotherapy (RayStation ECHO, Varian Ethos IOE, Limbus auto-contouring)

    The 2022-2026 period has seen AI planning tools move from knowledge-based assistance to autonomous plan generation for routine cases. RayStation v2025's ECHO algorithm produces clinical-quality VMAT and IMRT plans from dosimetrist-defined constraint hierarchies without iterative manual parameter adjustment. Varian Ethos generates a new adaptive plan at each treatment fraction from the daily CBCT, with the dosimetrist's role shifting entirely upstream (reference plan and constraint hierarchy) and downstream (quality assurance across fractions). Auto-contouring platforms (Limbus Contour, MIM ContourProtege, Mirada DLCExpert) handle 70-80% of organ-at-risk structure delineation without manual dosimetrist input. The combination represents the most significant role transformation since IMRT: the dosimetrist who invested heavily in plan generation expertise finds that work increasingly automated, while the dosimetrist who built AI governance skills, complex case expertise, and adaptive therapy specialization is commanding $140,000-$180,000+ at leading cancer centers.

    Effect on the work

    The net employment effect of AI planning tools is contested. BLS projects 3% employment growth 2024-2034 despite automation, driven by an aging population increasing cancer demand. The composition of the workforce is shifting: routine plan generation roles face compression while AI governance, adaptive therapy, and complex case roles are in short supply and commanding salary premiums.

    Work toolChanging equipment
Projection cone · present → 2034

What credible sources project

Scrub the slider past now to anchor each scenario on the scrubber. The spread is the range of futures credible sources project for this role.

Employment outlook
Projected change in the number of people doing this work.
AAMD Workforce Study (Medical Dosimetry, 2014-2024)
2034
+8%
Moderately optimistic workforce projection based on AAMD workforce study projections that cancer incidence growth and retirement of the aging dosimetry workforce (median age 47 in 2020) will create more openings than AI planning automation will suppress. The AAMD workforce model predicted undersupply starting around 2028-2030 as the large cohort of dosimetrists who entered the field in the 1990s-2000s retire simultaneously with the baby boomer cancer demand surge. This projection is more optimistic than the BLS base case because it weights supply-side constraints (retirements, limited JRCERT program seats) more heavily than automation headwinds.
BLS Occupational Outlook Handbook 2024-34
2034
+3%
BLS OOH employment projections model for 29-2036 Medical Dosimetrists, 2024-2034 cycle. The 3% growth projection reflects two opposing forces: cancer incidence growth from an aging US population increases demand for radiation therapy and therefore for dosimetrists; this is partially offset by AI planning automation that increases dosimetrist throughput (more plans per dosimetrist per day with KBP and auto-planning tools). BLS classifies this as "about as fast as average" growth. The small size of the workforce (4,800 jobs) means the absolute new job count is modest (~200 openings per year on average), but the profession is not projected to shrink.
AI task exposure
Share of the role’s tasks that researchers estimate AI can do. This is a measure of task exposure, not a forecast of jobs lost.
PMC 11839879 — AI in Radiation Oncology Planning (2025)
2030
65%
of tasks
Estimate of routine plan generation task exposure to AI automation, derived from clinical evidence in the 2025 PubMed Central review of AI in radiation oncology. Institutions deploying RapidPlan KBP and ECHO auto-planning report 40-70% reduction in planning time for routine sites (prostate, breast, lung, H&N), consistent with approximately 65% of routine planning tasks being addressable by current AI tools. This is NOT a projection of job loss: the same study notes that dosimetrist roles are shifting to AI governance, complex case oversight, and adaptive planning quality assurance. The exposure figure captures what fraction of the current task repertoire is affected, not how many dosimetrists will lose their jobs.
Today, in this role

What's shifting in the work right now

The historical view above shows how this role has moved. This is the present-day detail: which AI tools are picking up which tasks, where the edge still is, and the natural directions this work can grow.

What's changing in your day

Three parts of your work where AI is already doing real lifting, and what stays yours.

AI is sitting alongside you hereGenerate and optimize IMRT and VMAT radiation treatment plans using knowledge-based planning (KBP) and auto-planning tools — initiating RapidPlan DVH estimation or ECHO auto-planning for routine treatment sites (prostate, breast, lung, head and neck)

Generate and optimize IMRT and VMAT radiation treatment plans using knowledge-based planning (KBP) and auto-planning tools — initiating RapidPlan DVH estimation or ECHO auto-planning for routine treatment sites (prostate, breast, lung, head and neck); reviewing AI-generated optimization objectives against institutional plan quality benchmarks; manually adjusting beam parameters, arc geometry, and dose constraints for cases where auto-planning outputs fail to meet clinical standards; and producing the final dosimetrist-approved plan for physicist sign-off and physician prescription.[4],[3],[8]

Where your edge is

RapidPlan KBP and ECHO auto-planning are reducing routine plan generation time by 40-70% at deployed sites — a 2-4 hour prostate VMAT becomes a 15-30 minute review-and-approve workflow. This is not a threat to hide from; it is the productivity leverage that allows you to focus on complex cases. The dosimetrists who thrive in this environment are the ones who develop three specific skills: (1) judging plan quality rapidly — knowing which DVH curves indicate a suboptimal plan before the optimizer finishes, not just after; (2) manual override expertise for complex cases (H&N IMRT, cranial SRS, re-irradiation) where auto-planning models are least reliable; and (3) RapidPlan model governance — understanding how institutional training data shapes model performance and when a model needs retraining.

AI is sitting alongside you hereReview and approve AI auto-contouring outputs before treatment plan optimization — importing structure sets generated by Limbus Contour, MIM ContourProtege AI, or Mirada DLCExpert into the treatment planning system

Review and approve AI auto-contouring outputs before treatment plan optimization — importing structure sets generated by Limbus Contour, MIM ContourProtege AI, or Mirada DLCExpert into the treatment planning system; systematically evaluating each OAR and target volume for contouring accuracy against the simulation CT and any fused MRI or PET datasets; editing AI-generated contours for anatomical errors (over-extension into adjacent organs, missed structure boundaries, registration mismatches in fused image sets); approving the final structure set as the dosimetrist of record before the optimization step begins.[9],[10]

Where your edge is

AI auto-contouring now handles the majority of structure delineation at sites with Limbus, MIM ContourProtege, or Mirada DLCExpert deployed — 70.3% of structure sets require only minor or no modification (BIR 2022 clinical evidence). The dosimetrist's role is the expert review gate: the AI segments; you validate anatomical accuracy and catch the errors that matter most clinically (a bladder contour that cuts through the prostate base, a brainstem boundary that drifts into the posterior fossa tumor). Study the specific failure patterns of your department's auto-contouring tool by treatment site — AI models have predictable weaknesses (e.g., bowel delineation on days with gas, neck lymph node levels in obese patients, rectal wall in the low pelvis). Dosimetrists who develop strong contouring review expertise become the quality gateway the team depends on, not just a pass-through approver.

AI is sitting alongside you hereDesign and validate reference treatment plans for adaptive radiotherapy patients — creating the reference plan (simulation CT-based) with dosimetrist-defined optimization constraints that will govern the Varian Ethos Intelligent Optimization Engine (IOE) or Elekta ONE Online adaptive plan generation throughout the treatment course

Design and validate reference treatment plans for adaptive radiotherapy patients — creating the reference plan (simulation CT-based) with dosimetrist-defined optimization constraints that will govern the Varian Ethos Intelligent Optimization Engine (IOE) or Elekta ONE Online adaptive plan generation throughout the treatment course; setting the constraint hierarchy (target coverage priority, OAR dose limits, optimization weights) that defines the AI optimizer's decision-making envelope for all subsequent fraction adaptations; and verifying that the reference plan meets prescription requirements and will produce clinically acceptable adaptive plans across expected anatomical variation scenarios.[11],[5]

Where your edge is

Adaptive planning governance is the highest-value emerging responsibility in the dosimetrist's role. When Ethos or Elekta ONE generates a new plan at each treatment fraction, the quality of every adapted plan is bounded by the constraint hierarchy you set in the reference plan. Poor upstream planning propagates as systematic quality error across 20-45 adaptive fractions. Develop deep expertise in constraint optimization for the treatment sites your center adapts (prostate SBRT, rectum, cervix, H&N) — understanding which constraint hierarchies produce robust adaptive plans when anatomy shifts vs. which fail in the presence of daily bowel gas or bladder variation. Dosimetrists who specialize in adaptive planning at high-volume adaptive therapy centers command premium salaries and are in short supply nationally.

Where this role is heading

Natural next steps for someone with your foundation: not exits, evolutions.

A direction you could grow

Medical and Health Services Managers

Experienced dosimetrists are strong candidates for radiation oncology department leadership roles: chief dosimetrist, radiation oncology program director, and cancer center operations manager. These positions manage the clinical, operational, and quality programs of a radiation therapy department — staffing, equipment planning, vendor contract management for TPS and linac platforms, accreditation compliance (ACR, ASTRO APEx), and radiation safety program oversight. As AI planning tools (RapidPlan, AutoPlan, Ethos) become standard infrastructure, administrators who understand the clinical and technical dimensions of AI-enabled radiation oncology are increasingly valued by health system leadership. Dosimetrists who add an MHA or MBA credential position themselves for department director roles at $120,000-$200,000+, with large academic cancer center directors exceeding that range.

What you'd add
  • · MHA or MBA with healthcare concentration — programs at UAB, Ohio State, George Washington, and online programs from ACHE-member institutions allow concurrent clinical practice during the degree
  • · Regulatory and accreditation compliance: ACR radiation oncology practice standards, ASTRO APEx accreditation, Joint Commission radiation oncology requirements, NRC/Agreement State materials license management for linac programs
  • · Operational analytics: linac utilization metrics, patient throughput modeling, staffing ratios for adaptive vs. conventional programs, AI planning tool ROI quantification for capital planning justification
  • · AI vendor management: evaluating proposals from Varian, RaySearch, Elekta, and Radformation for TPS, adaptive therapy, and planning automation investments; building institutional business cases for AI planning tools; understanding total cost of ownership including physicist and dosimetrist time for model governance
What it takesSome new skills to pick up
Share this year
Drops anyone you send it to straight into 2026.
Preview card
Part of Healthcare · see all 69roles →
Different role?

See the same long-arc view for your own profession.

Browse the directory by industry, or search by title or SOC code. New roles ship every few weeks. Every profile cites every claim.

Browse all roles

The data behind this timeline

On record since1951
Latest tracked employment4,800 (US, 2024)
Latest median pay$138,110 (2024)
Outlook+3% by 2034 (BLS Occupational Outlook Handbook 2024-34)
View all 7 cited data points
YearUS employmentMedian annual paySource
19751,500n/aESTIMATE
19883,000$28,000ESTIMATE
20125,500$95,000ESTIMATE
20214,600$127,270BLS-OEWS
20223,190$128,970BLS-OEWS
20233,900$132,880BLS-OEWS
20244,800$138,110BLS-OEWS
Embed this timeline on your site

Free for any site. Paste this where the timeline should appear; it stays interactive, every datapoint stays cited, and it sets no cookies on your page. How embedding works

<iframe src="https://futurehistory.earth/embed/29-2036"
  width="100%" height="430" style="border:0"
  title="Medical Dosimetrists, a Future History timeline"
  loading="lazy"></iframe>

See all roles in Healthcare